Detalles de la búsqueda
1.
Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection.
N Engl J Med
; 382(13): 1232-1243, 2020 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32212519
2.
Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants.
Antimicrob Agents Chemother
; 66(4): e0225121, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35315687
3.
Prevalence of gp160 polymorphisms known to be related to decreased susceptibility to temsavir in different subtypes of HIV-1 in the Los Alamos National Laboratory HIV Sequence Database.
J Antimicrob Chemother
; 76(11): 2958-2964, 2021 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34297843
4.
Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense® Entry assay.
J Antimicrob Chemother
; 76(3): 648-652, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33241285
5.
Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid-dependent, human immunodeficiency virus seronegative participants.
Br J Clin Pharmacol
; 85(8): 1771-1780, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30980734
6.
Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study.
J Hepatol
; 62(1): 56-63, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25176615
7.
Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.
Gastroenterology
; 143(3): 619-628.e1, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22643350
8.
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.
Liver Transpl
; 19(8): 887-95, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23788462
9.
Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals.
Patient
; 15(1): 131-143, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34180035
10.
Evaluation of the pharmacokinetic drug-drug interaction between the antiretroviral agents fostemsavir and maraviroc: a single-sequence crossover study in healthy participants.
HIV Res Clin Pract
; 23(1): 1-8, 2021 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35285786
11.
Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Temsavir, the Active Moiety of Fostemsavir.
J Clin Pharmacol
; 61(7): 939-953, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33368327
12.
Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1.
AIDS
; 35(7): 1061-1072, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33946085
13.
Effects of Temsavir, Active Moiety of Antiretroviral Agent Fostemsavir, on QT Interval: Results From a Phase I Study and an Exposure-Response Analysis.
Clin Transl Sci
; 13(4): 769-776, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32027457
14.
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study.
Lancet HIV
; 7(11): e740-e751, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33128903
15.
Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B.
J Gastroenterol Hepatol
; 29(7): 1485-93, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25587617
16.
Large-scale surveillance study of the safety and effectiveness of entecavir in Korean patients with chronic hepatitis B.
Korean J Intern Med
; 33(1): 91-101, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29228519
17.
Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial.
PLoS One
; 13(10): e0205368, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30352054
18.
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
World J Gastroenterol
; 21(15): 4644-51, 2015 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25914474
19.
The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B.
J Clin Transl Hepatol
; 1(1): 51-8, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26357607
20.
Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir.
Antivir Ther
; 18(5): 691-8, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23510982